Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 3/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | MGAM | O43451 | 1/20 | 0.33 |
| ▸ | SI | P14410 | 1/20 | 0.33 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | TSHR | P16473 | 2/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | CRHBP | P24387 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1149475 | 1.00 | ALOX15 (0.42) | ALOX15GAAL3MBTL1MGAMSI | |
| SCHEMBL28815661 | 0.76 | GAA (0.39) | ALOX15GAAL3MBTL1MGAMSI | |
| SCHEMBL2338040 | 0.76 | GAA (0.39) | ALOX15GAAL3MBTL1MGAMSI | |
| SCHEMBL12003317 | 0.74 | GLA (0.39) | ALOX15GAAL3MBTL1MGAMSI | |
| SCHEMBL3260744 | 0.73 | HCAR2 (0.48) | GAAL3MBTL1MGAMSIMGAM2 | |
| SCHEMBL11601388 | 0.71 | GLA (0.41) | GAAL3MBTL1MGAMSIMGAM2 | |
| SCHEMBL12393899 | 0.71 | NR1I2 (0.45) | ALOX15GAAMGAMSIMGAM2 | |
| SCHEMBL9772247 | 0.71 | GAA (0.36) | GAAL3MBTL1MGAMSIMGAM2 | |
| SCHEMBL1147121 | 0.71 | — | — | |
| SCHEMBL2335067 | 0.71 | CYP2C9 (0.41) | GAAL3MBTL1MGAMSIMGAM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110034510-A1 | ENANTIOMER-ENRICHED ALPHA-,OMEGA-AMINO ALCOHOL DERIVATIVES, THEIR PRODUCTION AND USE AS INSECT- AND MITE-REPELLING AGENTS | SALTIGO GMBH (DE) | 2011-02-10 | — | — | US | disclosed |
| US-5008261-A | Long-lasting | BAYER AKTIENGESELLSCHAFT (DE) | 1991-04-16 | — | — | US | disclosed |
| US-4900834-A | INSECT AND MITE REPELLENTS | BAYER AKTIENGESELLSCHAFT (DE) | 1990-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110034510-A1 | ENANTIOMER-ENRICHED ALPHA-,OMEGA-AMINO ALCOHOL DERIVATIVES, THEIR PRODUCTION AND USE AS INSECT- AND MITE-REPELLING AGENTS | CHRM1, CHRNE, YWHAZ | ALOX15 154/4885GAA 4861/4885L3MBTL1 80/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.